These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children. Bellone J, Bellone S, Aimaretti G, Valetto MR, Baffoni C, Corneli G, Origlia C, Arvat E, Ghigo E. J Endocrinol Invest; 2000 Mar; 23(3):158-62. PubMed ID: 10803472 [Abstract] [Full Text] [Related]
7. GH responsiveness to repeated GHRH or hexarelin administration in normal adults. Sartorio A, Conti A, Ferrero S, Spada A, Faglia G. J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303 [Abstract] [Full Text] [Related]
8. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B. Regul Pept; 1997 May 14; 70(1):49-54. PubMed ID: 9250581 [Abstract] [Full Text] [Related]
10. Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men. Cappa M, Setzu S, Bernardini S, Carta D, Federici G, Grossi A, Loche S. J Endocrinol Invest; 1995 Nov 14; 18(10):762-6. PubMed ID: 8787952 [Abstract] [Full Text] [Related]
11. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans. Ghigo E, Gianotti L, Arvat E, Ramunni J, Valetto MR, Broglio F, Rolla M, Cavagnini F, Müller EE. J Clin Endocrinol Metab; 1999 Jan 14; 84(1):285-90. PubMed ID: 9920097 [Abstract] [Full Text] [Related]
12. Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin. Rigamonti AE, Cella SG, Marazzi N, Müller EE. Eur J Endocrinol; 1999 Sep 14; 141(3):313-20. PubMed ID: 10474131 [Abstract] [Full Text] [Related]
13. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E. Metabolism; 1995 Jan 14; 44(1):134-8. PubMed ID: 7854159 [Abstract] [Full Text] [Related]
14. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E. J Clin Endocrinol Metab; 1994 Nov 14; 79(5):1440-3. PubMed ID: 7962341 [Abstract] [Full Text] [Related]
15. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. Arvat E, Di Vito L, Ramunni J, Gianotti L, Giordano R, Deghenghi R, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1997 Oct 14; 47(4):495-500. PubMed ID: 9404449 [Abstract] [Full Text] [Related]
16. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone. Conley LK, Brogan RS, Giustina A, Wehrenberg WB. Pituitary; 2000 May 14; 2(4):253-60. PubMed ID: 11081146 [Abstract] [Full Text] [Related]
17. Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. Giustina A, Bussi AR, Deghenghi R, Imbimbo B, Licini M, Poiesi C, Wehrenberg WB. J Endocrinol; 1995 Aug 14; 146(2):227-32. PubMed ID: 7561633 [Abstract] [Full Text] [Related]